Acasti Pharma Correlations
| ACSTDelisted Stock | USD 3.37 0.01 0.30% |
The current 90-days correlation between Acasti Pharma and Tonix Pharmaceuticals Holding is 0.15 (i.e., Average diversification). The correlation of Acasti Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Acasti Pharma Correlation With Market
Significant diversification
The correlation between Acasti Pharma and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Acasti Pharma and DJI in the same portfolio, assuming nothing else is changed.
Acasti |
Moving together with Acasti Stock
| 0.85 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.64 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.74 | WMT | Walmart Aggressive Push | PairCorr |
| 0.68 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.69 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.75 | CSCO | Cisco Systems Aggressive Push | PairCorr |
Moving against Acasti Stock
| 0.88 | KO | Coca Cola Sell-off Trend | PairCorr |
| 0.87 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.85 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.84 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.83 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.73 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.67 | PBCRY | Bank Central Asia | PairCorr |
| 0.59 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.52 | PBCRF | PT Bank Central | PairCorr |
| 0.51 | PTAIY | Astra International Tbk | PairCorr |
| 0.49 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Acasti Stock performing well and Acasti Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Acasti Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TNXP | 5.61 | (1.10) | 0.00 | (0.19) | 0.00 | 14.29 | 34.76 | |||
| JAGX | 2.89 | (0.24) | 0.00 | (0.19) | 0.00 | 8.13 | 27.65 | |||
| DFFN | 2.40 | (0.49) | 0.00 | 3.01 | 0.00 | 4.09 | 12.34 | |||
| IBIO | 3.76 | 0.43 | 0.09 | 0.98 | 3.54 | 7.76 | 30.48 | |||
| ARDS | 7.73 | 1.48 | 0.10 | (0.53) | 7.66 | 12.50 | 140.53 | |||
| AKTX | 4.56 | (1.50) | 0.00 | 3.41 | 0.00 | 6.04 | 47.27 | |||
| ADTX | 7.85 | (6.15) | 0.00 | (7.43) | 0.00 | 6.25 | 50.07 | |||
| ABVC | 3.73 | (0.27) | 0.00 | 0.52 | 0.00 | 7.25 | 35.84 | |||
| PULM | 5.31 | 2.30 | 0.47 | (4.66) | 3.27 | 12.29 | 92.85 | |||
| ONTX | 4.73 | 1.02 | 0.15 | (0.58) | 4.35 | 7.69 | 66.73 |
Delisting Warning - ACST
Acasti Pharma was delisted
| The entity Acasti Pharma with a symbol ACST was delisted from NASDAQ Exchange. Please try Grace Therapeutics, with a symbol GRCE from now on. Check all delisted instruments accross multiple markets. |
Acasti Pharma Corporate Management
| Amresh Kumar | VP Management | Profile | |
| Carrie DAndrea | VP Operations | Profile | |
| George Kottayil | Chief US | Profile | |
| Robert CPA | Principal Officer | Profile | |
| Prashant Kohli | Chief Officer | Profile | |
| Yves Lachance | VP Compliance | Profile |
Still Interested in Acasti Pharma?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.